The Use of Small Molecular Inhibitors in Treating Cancer You are working in a lab that focuses on studying cancer. Your lab is looking for proteins to target with small molecule inhibitors to try to stop the over-proliferative, over-mutative, and/or over-survival phenotype of cancer cells. For each of the following proteins, would developing a “small-molecule” inhibitor (a molecule that can bind the protein and inhibit its function in some way) be a good way to treat cancer cells? Explain your reasoning for each. A. A small molecule inhibitor that inhibits the ability of tubulin to hydrolyze GTP B. A small molecule inhibitor that inhibits PTEN (the phosphatase that switches PIP3 to PIP2 in the survival signaling pathway) C. A small molecule inhibitor of BAD D. A small molecule inhibitor of RGS (assume that this GPCR pathway is involved in cell division signaling, as some are)

Order with us today for a quality custom paper on the above topic or any other topic!

What Awaits you:

• High Quality custom-written papers

• Automatic plagiarism check

• On-time delivery guarantee

• Masters and PhD-level writers

• 100% Privacy and Confidentiality